Find a company by name or ticker and open its page
We use analytics cookies to understand how you use Stockoscope and improve the platform. Essential cookies that keep you logged in are always on. Cookie policy
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
TMOBenzingaEach week, Benzinga's Stock Whisper Index uses proprietary data and pattern recognition to highlight five stocks just under the surface that deserve attention.
Also in the news
TMO247 WallstA wild Thursday saw Treasury yields crater, oil surge past $111, crypto liquidations top $431 million, and Meta's cash flow surprise rattle markets. Now analysts are reshuffling their calls on some of the week's most closely watched names.
TMOSeeking AlphaThermo Fisher Scientific Inc. delivered strong Q3 results, with 6% organic growth, EPS and sales beats, and raised full-year guidance. TMO's growth is driven by robust demand in clinical research, bioproduction, and electron microscopy, supported by recent strategic acquisitions. Operating margin reached 24.5%, aided by divestitures, acquisitions, and ongoing process improvements.
TMOSeeking AlphaThermo Fisher Scientific Inc. delivered 6% organic growth, 120 bps margin expansion, and 39% free cash flow growth in Q3, validating the ongoing recovery. I maintain a Strong Buy rating on TMO, supported by accelerating earnings, improved profitability, and a declining net debt/EBITDA ratio (now 2.9x). Laboratory Products and Biopharma Services led with 10% organic growth, while Analytical Instruments posted 430 bps margin expansion, though Life Sciences and Diagnostics remain slower.
TMOBenzingaU.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 1% on Wednesday.
TMOZacks Investment ResearchThermo Fisher beats Q3 earnings and revenue estimates, with double-digit profit growth and wider margins, yet shares fall 4.1% in pre-market trading.
TMOSeeking AlphaThermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call Transcript
TMOBusiness WireWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 26, 2026. Third Quarter Highlights Third quarter revenue grew 9% to $12.14 billion Third quarter GAAP diluted earnings per share (EPS) grew 9% to $4.64 Third quarter adjusted EPS grew 15% to $6.68 “We are very pleased to deliver another excellent quarter, with outstanding financial performance on both the top.
TMOZacks Investment ResearchAlthough the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
TMOZacks Investment ResearchThermo Fisher Scientific (TMO) came out with quarterly earnings of $6.68 per share, beating the Zacks Consensus Estimate of $6.4 per share. This compares to earnings of $5.79 per share a year ago.